-
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
-
Every social justice movement is impacted by the Long COVID crisis
-
A toolkit for new advocates: What I learned from the Long COVID Moonshot campaign
-
Thousands “lie in” for German ME protests
-
Long COVID advocates demand biological research at a conference in Paris
-
COVID-19 spreads year round. Here’s how to track it.
-
Long COVID is significantly underreported across the globe
Science
Covid-19
Health
-
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?
-
Every social justice movement is impacted by the Long COVID crisis
-
Mold exposure can trigger and worsen chronic illness. Climate change will increase the risk.
-
What is the link between climate change and chronic illness?
-
Breaking the vicious cycle: How two German scientists seek to solve ME
-
RECOVER’s first round of clinical trials are failing. Will the next phase be better?
-
How do you get people to care about COVID-19? Here’s what I’ve learned as an organizer.
-
Long COVID taught me to slow down and stop trying to meet able-bodied benchmarks
-
Posthumous album of singer Kara Jane released on Severe ME Awareness Day
-
As a linguist, I want to find the words to measure chronic illness